C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer

被引：0
|
作者：
Tsakonas, G. [1 ]
Hirsch, F. R. [2 ]
Ekman, S. [1 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
c-Met; non-small cell lung cancer; early stage;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-070
引用
收藏
页码：S2124 / S2125
页数：2
相关论文
共 50 条
  • [41] Analysis of C-MET Amplification Non-Small Cell Lung Cancer Cell Blocks from Pleural Effusion
    Xu, C.
    Wang, W.
    Zhuang, W.
    Chen, G.
    Tian, Y.
    Xu, J.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1944 - S1945
  • [42] Quantitative severity of lobar emphysema is not associated with location of lung cancer in patients with surgically resected non-small cell lung cancer
    Lee, S. J.
    Yoon, S. S.
    Ju, S.
    Yoo, J. W.
    Jeong, Y. Y.
    Lee, J. D.
    ANNALS OF ONCOLOGY, 2017, 28 : 121 - 121
  • [43] Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
    I. Watermann
    B. Schmitt
    F. Stellmacher
    J. Müller
    R. Gaber
    Ch. Kugler
    N. Reinmuth
    R. M. Huber
    M. Thomas
    P. Zabel
    K. F. Rabe
    D. Jonigk
    A. Warth
    E. Vollmer
    M. Reck
    T. Goldmann
    Diagnostic Pathology, 10
  • [44] Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
    Watermann, I.
    Schmitt, B.
    Stellmacher, F.
    Mueller, J.
    Gaber, R.
    Kugler, Ch.
    Reinmuth, N.
    Huber, R. M.
    Thomas, M.
    Zabel, P.
    Rabe, K. F.
    Jonigk, D.
    Warth, A.
    Vollmer, E.
    Reck, M.
    Goldmann, T.
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [45] Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
    Yao, Shuxi
    Liu, Xinyue
    Feng, Yanqi
    Li, Yiming
    Xiao, Xiangtian
    Han, Yuelin
    Xia, Shu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [46] The HGF/c-Met pathway activates COX-2 in non-small cell lung cancer
    Siegfried, Jill M.
    Gubish, Christopher T.
    de Oliveira, Pierre E. Queiroz
    Stabile, Laura P.
    CANCER RESEARCH, 2006, 66 (08)
  • [47] Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification
    Caixia Ding
    Yanyi Qiu
    Juan Zhang
    Wei Wei
    Hongbian Gao
    Yong Yuan
    Xiaomin Wang
    BMC Pulmonary Medicine, 23
  • [48] Consistency analysis of c-Met protein expression over time in patients with non-squamous non-small cell lung cancer
    Cortot, A. B.
    Dubois, R.
    Gregoire, V.
    Gibier, J-B.
    Labreuche, J.
    Deprez, V.
    Dubrulle, D.
    Chretien, T.
    Wasielewski, E.
    Behal, H.
    Feng, D.
    Lind, A.
    Ansell, P. J.
    Thiebaut, R.
    Hader, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S282 - S282
  • [49] The association of topoisomerase 2α expression with prognosis in surgically resected non-small cell lung cancer (NSCLC) patients
    Erguden, Hulya Celenk
    Koksal, Deniz
    Demirag, Funda
    Bayiz, Hulya
    Mutluay, Neslihan
    Berktas, Bahadir
    Berkoglu, Mine
    JOURNAL OF THORACIC DISEASE, 2012, 4 (04) : 352 - 357
  • [50] Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer
    Jin Sakamoto
    Makoto Sonobe
    Masashi Kobayashi
    Masashi Ishikawa
    Ryutaro Kikuchi
    Daisuke Nakajima
    Tetsu Yamada
    Ei Nakayama
    Tsuyoshi Takahashi
    Toshihiko Sato
    Fengshi Chen
    Toru Bando
    Hiroshi Date
    International Journal of Clinical Oncology, 2014, 19 : 50 - 56
12345